After several acts at the U.K. festival Glastonbury led chants in support of Palestinian freedom and denouncing the Israel Defense Forces, U.K. police opened a criminal investigation into their performances.
Several outlets including the BBC cited a statement from Avon and Somerset police in the U.K. announcing an inquiry into sets by the rap-punk group Bob Vylan and the Northern Irish rap group Kneecap.
During Bob Vylan’s set, the band’s singer Bobby Vylan (born Pascal Robinson-Foster) led Glastonbury crowds in chants of both “free, free Palestine” and, more controversially, “death, death to the IDF.”
Though police did not cite specific actions that were being investigated, “This has been recorded as a public order incident at this time while our enquiries are at an early stage,” the statement read. “The investigation will be evidence-led and will closely consider all appropriate legislation, including relating to hate crimes.”
The BBC, which broadcast Bob Vylan’s set, said in a statement that “The antisemitic sentiments expressed by Bob Vylan were utterly unacceptable and have no place on our airwaves.” The network added that it “respects freedom of expression but stands firmly against incitement to violence.” Glastonbury’s organizers said in a statement that they were “appalled” by Vylan’s comments, which they said “crossed a line.”
The U.S. State Department also announced the the two members of Bob Vylan would have their U.S. visas revoked. “Foreigners who glorify violence and hatred are not welcome visitors to our country,” U.S. Deputy Secretary of State Christopher Landau said on social media.
The BBC did not broadcast the Glastonbury set from the acclaimed Belfast rap trio Kneecap, which has attracted worldwide attention for its outspoken criticism of Israel’s war on Gaza, including at its recent Coachella sets.
Kneecap instead reportedly roused the crowd in a profane chant against U.K. Prime Minister Keir Starmer, who had criticized their booking at the festival after the group’s Liam Óg Ó hAnnaidh, who performs as Mo Chara, was charged with supporting a proscribed organization for allegedly waving a flag from the terror group Hezbollah at a London concert in 2024 (Chara denied the charge).
U.K. prosecutors, citing time limits, recently dropped charges against the group after a 2023 concert where Chara allegedly said, “The only good Tory is a dead Tory. Kill your local MP.”
After the performance, talent agency UTA reportedly dropped Bob Vylan from its roster. Singer Bobby Vylan stood by his comments, writing on social media that “Teaching our children to speak up for the change they want and need is the only way that we make this world a better place.”
Advanced lab-grown tissues help show how special lung cells develop, shedding light on rare ACDMPV disease and suggesting potential ways to repair damage from viral infections such as COVID-19
CINCINNATI, June 30, 2025 /PRNewswire/ — A team of experts at Cincinnati Children’s reports another powerful step forward in organoid medicine: success at making human lung tissue that can produce its own blood vessels.
Their findings, published in the same month as a similar success involving liver organoids, reflect a new wave of advanced lab-grown tissues that can be used immediately in many research applications while moving ever closer to serving as living tissues that can directly repair damaged organs.
Whole-mount staining of embryonic mouse lung alveolar vasculature (white) and epithelium (pink). Source: Yifei Miao and Hill Chang.
Details were posted online June 30, 2025, in the journal Cell.
“Prior to our study, the development of lung organoids with organotypic vasculature had not been achieved,” says co-corresponding author Mingxia Gu, MD, PhD. “Notably, this method also could be applied to other organ systems such as intestine and colon.”
Gu, now at UCLA, was a member of the Center for Stem Cell and Organoid Medicine (CuSTOM) and Division of Pulmonary Biology at Cincinnati Children’s while this research was conducted. Co-first and co-corresponding author Yifei Miao, PhD, (now at the Chinese Academy of Sciences, Beijing) also was with Cincinnati Children’s for this work. Co-corresponding author Minzhe Guo, PhD, remains with Cincinnati Children’s along with several co-authors involved in this study.
Overcoming a major challenge
Researchers have been working for years to grow organoids — sometimes called “organs in a dish.”
Creating organoids involves converting mature human cells (such as blood or tissue cells) back into fetal-like stem cells that can be coaxed into growing a wide range of other tissue types. Unlike disconnected human cells kept alive in a dish, these are growing, developing mini-organs that form into seed-sized spheres that mimic the unique functions of full-sized organs.
Intestines that absorb and secrete. Stomachs that produce digestive acids. Hearts that pulse. Brain tissues with firing nerve cells and so on.
Cincinnati Children’s has been a leader in organoid development since 2010 when experts here produced the world’s first functional intestinal organoid grown from induced pluripotent stem cells (iPSCs).
More recently, the challenge has been learning how to grow organoid tissues that can connect with the rest of the body to integrate nerve connections, blood vessels, bile ducts, immune systems and more. During pregnancy, these differing tissue types naturally find each other as the fetus matures and becomes more complex. Organoid developers seek to re-produce these steps in the laboratory, which eventually may allow people to receive custom-grown tissues that could patch damage or boost disrupted functions.
Simpler forms of organoids have already begun transforming medical research, allowing many scientists to use living human tissue models to study disease while reducing current reliance on animal models to develop new medicines. But without the ability to make internal blood vessels, the tiny seeds lack the ability to grow into larger, more useful tissues.
How the team solved the vascular riddle
The new study thoroughly recounts the results of many experiments the team conducted to demonstrate success at inducing blood vessel formation. The work spanned four years and involved more than 20 people at Cincinnati Children’s plus collaborations with experts at several other organizations.
“The challenge in vascularizing endodermal organs, particularly the lung, stems from different signaling requirements for lung epithelial versus vascular differentiation,” says Miao. “Our success in this endeavor is attributable to our unique differentiation method.”
In essence, the team grew iPSCs from multiple cell types then found the right moment to introduce them to each other. The resulting cell signals helped flip a developmental switch so that progenitor cells that could have become either blood vessels or the outer walls of the lung wound up becoming blood vessels. In achieving this vital step, the team:
Produced lung organoids that include respiratory bronchial epithelial cells (RAS cells), a human cell type not previously reported in conventional lung organoid models.
Pinned down the developmental moments when a rudimentary gut tube begins to send some cells to form the lungs while sending other cells to form the stomach and intestine. While the basic steps of this transformation have been studied in animals, it had not been possible to study this stage of development in humans without killing fetuses.
Demonstrated that the rare disease ACDMPV occurs when cell signaling “crosstalk” gets disrupted during this early blood vessel formation stage. Within days of birth, infants born with Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACDMPV) struggle to breathe because their lungs’ air sacs (alveoli) and blood vessels are malformed. Nearly all infants with this condition die within the first month of life, according to the National Organization for Rare Disorders.
Revealed key functional information about the cells involved in gas exchange inside the human lung. Their learnings help explain the damage within tiny blood capillaries that occurs in the lungs in response to injuries. These new clues offer fresh ideas for developing ways to protect and potentially restore affected lung tissues.
What’s Next?
Cincinnati Children’s has filed patent applications related to the methods developed here to produce organoids with blood vessel formation capabilities and the CuSTOM team is moving to further develop this technology.
“We look forward to continuing to learn more about the fundamental biology involved in organ formation and applying those discoveries to improving outcomes across a wide range of difficult human diseases and conditions,” says Aaron Zorn, PhD, co-director of CuSTOM and director of the Division of Developmental Biology.
In addition to publishing these findings in Cell, co-authors plan to present their work at the Keystone conference in Kyoto, Japan (iPSCs: Progress, Opportunities, and Challenges) in January 2026.
About the study
Cincinnati Children’s co-equal first authors were Miao, Nicole Pek, BS, and Cheng Tan, MD.
Contributing co-authors from Cincinnati Children’s were Cheng Jiang, MS, Zhiyun Yu, PhD, Kentaro Iwasawa, MD, PhD, Min Shi, MD, PhD, Daniel Kechele, PhD, Nambirajan Sundaram, PhD, Victor Pastrana-Gomez, MSTP student, Debora Sinner, PhD, Cheng-Lun Na, PhD, Keishi Kishimoto, PhD, Jason Tchieu, PhD, Jeffrey Whitsett, MD, Kyle McCracken, MD, PhD, Michael Helmrath, MD, James Wells, PhD, Takanori Takebe, MD, PhD, and Aaron Zorn, PhD.
Contributing co-authors included experts from Harvard Medical School, Icahn School of Medicine at Mount Sinai, Sophia Children’s Hospital (The Netherlands), Boston University
This research also was supported by the Discover Together Biobank, the Bio-Imaging and Analysis Facility, and the Integrated Pathology Research Core at Cincinnati Children’s and the University of Cincinnati Proteomics Laboratory.
Funding sources for this work included: the National Institutes of Health (R01HL166283, DK128799-01, N01-75N92020C00005 and R01HL095993); an Endowed Scholar Award from the Cincinnati Children’s Research Foundation; the American Heart Association (1013861 and 906513); the Falk Transformational Awards Program; and the Brigham Research Institute.
Learn more about working with CuSTOM
Learn how donors can support ongoing organoid research at Cincinnati Children’s
SOURCE Cincinnati Children’s Hospital Medical Center
MANCHESTER, United Kingdom, June 30, 2025 (GLOBE NEWSWIRE) — Following the roaring success of its annual winter Comedy Tour over the last decade, one of the UK’s leading humanitarian aid charities, Human Appeal, today announces its first ever summertime Comedy Tour.
Taking place across three major UK cities – London, Manchester and Birmingham – Human Appeal’s summer Comedy Tour will feature some of the biggest names in the international comedy circuit: American actor and comic Omar Regan, who appeared in Hollywood films Rush Hour 2, American Sharia, and Five Thirteen; Ali Official, writer and comic best known for BBC Three show Muzlamic and for presenting the BBC 3 film Being British Bangladeshi; and Aatif Nawaz, writer and star of BBC Three comedy Muzlamic, who joins the Comedy Tour for the 9th year running.
Whereas Human Appeal’s winter Comedy Tour reaches every corner of the UK at large capacity venues, the summer Comedy Tour features intimate shows for a much more personal audience experience.
Proceeds of the ticket sales for the summer Comedy Tour will support the charity’s Gaza Emergency Appeal.
The dates and times of the summer Comedy Tour shows are as follows:
Early bird tickets are available from13th June 2025 at just £7. Standard tickets will go sale on 13th July at £10. Further ticket information, including ticket bundles and VIP packages can be found here.
Announcing the news, Razwan Faraz, UK Director of Fundraising at Human Appeal, adds, ‘Our annual winter Comedy Tour has just celebrated its 10th anniversary, and following its success spreading festive cheer year on year, we felt it was time to expand our much-loved event. This is the first time we are bringing the Comedy Tour to smaller venues for much more intimate shows, during the summer months and bring comedy cheer all year round.’
Tickets are available to purchase here.
About Human Appeal
Human Appeal is a fully independent British humanitarian charity based in Manchester, UK. It was established in 1991 as a registered and regulated UK charity that runs targeted aid relief programmes in collaboration with recognised global organisations such as the UN. Its purpose is to save and transform lives through emergency aid response and sustainable development programmes at home and abroad across 25 countries worldwide.
Workers repaint the NASA logo on the Vehicle Assembly Building at the Kennedy Space Center on May 28, 2020 in Cape Canaveral, Florida.
Joe Raedle | Getty Images
NASA’s live programming, including rocket launches, spacewalks and views of Earth from space, will begin streaming on Netflix this summer.
NASA said the move is part of its effort to reach a global audience, according to a press release. The agency noted that the content will remain free and ad-free on the NASA app and website, where it already has live programming.
NASA+ launched in 2023 as a way to give the public easier access to space content.
“The National Aeronautics and Space Act of 1958 calls on us to share our story of space exploration with the broadest possible audience,” Rebecca Sirmons, general manager of NASA+, said in the release.
NASA did not disclose financial details of the deal.
The partnership comes as there has been a surge in commercial rocket launches, led by Elon Musk’s SpaceX. SpaceX has had 81 launches in the first half of 2025, according to Space Explored. It also continues to be the only U.S. company with a spacecraft that’s certified to bring astronauts to the International Space Station.
Meanwhile, NASA has been supporting missions in low-Earth orbit.
Shares of Netflix, which has more than 700 million users, have been trading at all-time highs. The streaming service is up almost 51% since the beginning of the year.
This year’s base Oppo Find X smartphone is tipped to gain at least a new 1/1.4-inch main camera and ultrasonic fingerprint scanner, predecessor pictured. (Image source: Oppo)
According to a new report from Digital Chat Station, Oppo will be bringing several upgrades to its cheaper flagship this year with the release of the Find X9 series. Mirroring rivals, the Oppo Find X9 is said to be adopting an ultrasonic fingerprint scanner with a new 50 MP and 1/1.4-inch main camera.
Oppo is not expected to kick off the Find X9 series for a few months yet. If the Find X8 and Find X8 Pro are anything to go by, then Oppo may hold off from introducing will wait until autumn rolls around before unveiling successors. With that being said, recent rumours suggest that MediaTek could allow Oppo to pull forward the release of its next-generation flagships to September.
In the meantime, Digital Chat Station has shared new details on Weibo about what is now believed to be the Find X9. According to the leaker, Oppo is currently developing the device with a 6.59-inch display surrounded by uniform bezels. While that size is unchanged from the Find X8, Digital Chat Station reports that Oppo will be swapping last generation’s optical fingerprint scanner for an ultrasonic equivalent to match rivals sold by Xiaomi and Samsung.
Likewise, the Dimensity 9500 will underpin a new 50 MP and 1/1.4-inch main camera. A periscope telephoto camera will be joining this new main camera, as will an updated design language. Reportedly, wireless charging support, a ‘large’ silicon battery and full waterproofing will be gracing the Find X9 too. Exact details in these regards remain unknown at this stage, though.
Alex Alderson – Senior Tech Writer – 12658 articles published on Notebookcheck since 2018
Prior to writing and translating for Notebookcheck, I worked for various companies including Apple and Neowin. I have a BA in International History and Politics from the University of Leeds, which I have since converted to a Law Degree. Happy to chat on Twitter or Notebookchat.
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market moves : The S & P 500 and Nasdaq were modestly higher Monday after logging record-high closes on Friday. They are both poised to close out June and the second quarter with strong gains. In the Homestretch of the last trading day of the month, we wanted to reflect on the first six months of the year as a perfect example of why you have to stay invested in the stock market — even when it is scary. Just three short months ago, the market started tanking on news that President Donald Trump was set on slapping major tariffs on U.S. trading partners to rectify what he believes to be unfair trade practices. While the “reciprocal” rates put on various countries were jaw-dropping, it’s pretty clear, in hindsight, that selling back then was the wrong move. There are a few lessons to be learned. 1. As it relates to Trump — and this is important because, love him or hate him, he is with us for another 3½ years — the dynamic is just another example of his negotiation style. The president likes to come out swinging when it comes to his demands — but in the end, he has shown a willingness to pull back on his asks in the pursuit of progress. If anything, the takeaway should be that the outcome of trade negotiations is almost assured to be less than what the president initially demanded. 2. This ties back to the first point; this style of negotiation, though perhaps not fun for investors, does tend to provide opportunities for the fundamental investors that can keep their focus on the longer term. It’s the idea of handicapping where negotiations will likely go after Trump’s initial shock and awe. Selloffs like the one at the beginning of April are broad-based and tend not to be very discerning, as big money investors look to unload exposure — selling first and asking questions later. As stock pickers, we have to be ready to game that, and the way to do that is to think less about the strong language, tough talk, and scary headlines — and instead, stick to our discipline and focus on what matters to stocks most: earnings. Yes, some companies will take direct hits due to tariffs, and all companies will be impacted in some way — be it through stresses on suppliers, partners, or consumer wallets. However, by focusing on longer-term trends and individual companies’ abilities to manage through the tariffs, we can find things to like in this market. Opportunities like those in cybersecurity, which will remain a high-priority spending category no matter what, given the costly implications of a data breach, or trends like artificial intelligence, which can provide an offset to rising costs, thanks to increases in efficiency. Jim Cramer talked about tech and other areas that look good in his Sunday column . While the consumer may take a hit, they are unlikely to stop shopping altogether. Instead, they will look for the best value around and shop in places like Club names Costco or off-price retailer TJX , or buy more stuff online from Amazon . The main point is, panic is not a strategy and as we noted a few weeks back in talking about the turmoil in the Middle East, as concerning as headlines might be, it’s not going to impact the market longer-term until investors start to sense that it will impact economic growth, inflation, and ultimately corporate earnings. While the trade war is ongoing, and the end-game is unclear, what is apparent is that many companies are going to be able to grow earnings regardless. As individual stock investors, that’s where we want to focus our buying power. Crypto craze : Robinhood hosted its “To Catch a Token” crypto event Monday, which was met with a positive reaction from investors. In addition to updates to the company’s crypto offerings, Robinhood laid out its plan to “tokenize” equity markets, essentially working to move much of the backend dynamics of equity trading to the blockchain. By moving to blockchain, Robinhood is not only revamping its platform to support 24/5 trading but setting the groundwork for 24/7 stock trading in the future. The move also sets up the ability for investors to store their stock tokens in cold storage wallets, similar to how some people currently store crypto when they want to move it off of an exchange and take full custody of the asset. Most exciting for financial markets, Robinhood is working on the “Robinhood Chain,” a blockchain that is “optimized for real-world assets from real estate, to art, to stocks,” according to the company. Apple news : According to a new Bloomberg article , Apple is thinking about using an outside firm’s AI to fix its efforts to deliver a new souped-up, conversation-like Siri. Anthropic or OpenAI are said to be under consideration, as in-house efforts have stumbled. Siri already punts to OpenAI’s ChatGPT to answer more elaborate questions. A recent Bloomberg report also said Apple was internally exploring a purchase of Perplexity AI. Apple had its first big theatrical win over the weekend, with “F1,” starring Brad Pitt, pulling $55.6 million in North America ticket sales and another $88.4 million internationally. It’s good to see the Club name’s movie studio grow and compete successfully on a larger stage, hopefully setting us up for more services growth. However, it’s far from enough to offset concerns about the iPhone maker’s AI strategy. Don’t expect much from the stock until investors gain more clarity on the company’s AI roadmap. Up next : Be sure to catch “Mad Money” on Monday evening for a free-ranging interview with Amazon CEO Andy Jassy. On Tuesday, we’ll be looking for updates to the shareholder return plans, buybacks, and dividends, from our financials, given the conclusion of the Federal Reserve’s positive stress test results. Club holdings Goldman Sachs and Wells Fargo are widely seen on Wall Street as the ones with the most improvement from last year. (See here for a full list of the stocks in Jim Cramer’s Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
A sea lion shows symptoms of domoic acid poisoning during a harmful algae bloom in Malibu, California, on April 24, 2002.
After starting her PhD studies in 2018, Monica Thukral would go for a swim off the coast of San Diego two to three times a week. The regular, physical connection with the waters helped to anchor her in her research at the University of California San Diego’s Scripps Institution of Oceanography.
“I had an understanding of the physical processes: how the temperature and the wave energy change throughout the year,” Thukral recalls. “I was the first to know when an algae bloom was taking place.”
In the laboratory, Thukral transformed that intuition into something more systematic. Using cutting-edge analytical tools, her team in the environmental systems biology lab of Andrew E. Allen—who also teaches at the nearby J. Craig Venter Institute, a genomics research foundation—strove to understand what was happening in the water on a molecular level.
The scientists were working in the wake of a momentous oceanographic event. In 2015, a massive harmful algal bloom (HAB) had subsumed a stretch of Pacific coastline from southern California all the way to Alaska’s Aleutian Islands. It flooded the region’s waters with domoic acid, a neurotoxin so dangerous that it gives sea lions epilepsy; government regulators shuttered some commercial fisheries for months.
How do you place a value on the loss of shellfish that you’ve been harvesting for centuries with your family?
Vera Trainer, Director, University of Washington’s Olympic Region Harmful Algal Bloom program
Produced by microalgae—namely, several species of marine diatoms known as Pseudo-nitzschia—domoic acid can bioaccumulate in the marine food web, eventually getting consumed by humans, in whom it can cause nausea, cardiac arrhythmia, and a condition called amnesic shellfish poisoning, which can include memory loss and disorientation. Once the acid has accumulated in shellfish tissues past an official threshold of 20 parts per million, regulators consider the meat unsafe for human consumption.
The 2015 HAB affected the West Coast more than any other recorded bloom in history, costing an estimated $97 million dollars in damages to the Dungeness crab harvest alone. Just a few months ago, a HAB again sickened wildlife off the coast of Southern California.
Domoic acid manifests in all of the world’s upwelling zones—coastal regions where winds push away warm surface water and draw cold, nutrient-rich waters to the surface. The neurotoxin is poised to become even more prevalent as warming oceans disturb the balance of nutrients available.
For years, scientists have been working to understand the mechanisms behind these blooms. “We’ve long held a range of hypotheses in this field for what initiates blooms of this particular organism and its toxin production,” says Clarissa Anderson, one of Thukral’s collaborators and the director of the Southern California Coastal Ocean Observing System (SCCOOS). “We all want to know, What is that magic sauce?”
Now Allen’s interdisciplinary team has figured out a way to potentially anticipate future toxic events. The researchers’ methods center around monitoring the algae-infused waters for environmental DNA (eDNA), material that is minute in concentration but rich in genetic information. In a paper published last year in Proceedings of the National Academy of Science, they pulled out all the stops to harvest, isolate, and analyze the genes behind the algal havoc (DOI: 10.1073/pnas.2319177121).
The mechanics of a bloom
Fans of classic cinema may already know domoic acid. In 1961, Alfred Hitchcock found himself inspired by a startling newspaper report about a frenzy of disoriented seabirds terrifying residents of coastal Santa Cruz, California. The director wove elements of that incident into his film The Birds 2 years later. Since then, similar incidents in Monterey Bay have linked addled avians to a diet temporarily infused with domoic acid, a product of Monterey Bay’s occasional HABs.
When stressed, Pseudo-nitzschia may release domoic acid for a number of reasons, like to impede the growth of competing plankton or to stave off algae-grazing crustaceans. Also, domoic acid has been found to serve as an iron chelator. The element is critical to photosynthesis, so when it becomes scarce, Pseudo-nitzschia will release domoic acid extracellularly, where it can bind to iron in the environment and make it easier for the algae to absorb.
HABs have likely always occurred as part of natural ecological cycles, but modern blooms appear to be becoming more toxic. Anderson says that over the past 20–30 years, deeper waters from the equatorial Pacific have seen rising levels of nitrogen and decreasing levels of silicate. These waters, which came up through the California undercurrent, likely contributed to the size and intense toxicity of 2015’s bloom.
“This massive bloom exhausted silicate before nitrate,” explains John Ryan, a researcher at the Monterey Bay Aquarium Research Institute and coauthor of the paper. Each diatom needs silicate to build its tough cell walls, like a tiny suit of glassy armor. If they run out of silicate, the diatoms can’t divide, but the nitrogen-rich waters continue to fuel their metabolism.
Faced with a silicon shortage threatening their ability to reproduce and an accompanying shortage in essential iron, the nitrogen-charged Pseudo-nitzschia along the Pacific coastline in 2015 took drastic action. The algae started producing as much as 10–20 times their usual amount of iron-scavenging domoic acid. As the compound built up in the Pseudo-nitzschia, each morsel of algae that nearby crustaceans ate became “phenomenally toxic,” Ryan says.
In 2018, Thukral’s fellow researcher in Allen’s lab, Patrick Brunson, helped identify DabA, a key enzyme that kick-starts Pseudo-nitzschia’s biosynthesis of domoic acid (Science, DOI: 10.1126/science.aau0382). The paper “was a milestone study,” Allen says. It handed researchers a compass to seek out genes that, like dabA, express themselves as a Pseudo-nitzschia bloom takes shape. Now the team wanted to learn what was happening one step before that.
Thukral, Brunson, and the rest of the team figured that because cells express genes before translating them into proteins, they could try to detect genes that Pseudo-nitzschia activated around the same time or even before dabA. These could serve as biological alarm bells that a HAB event was imminent.
In the wake of that paper, Brunson found himself the beneficiary of scientific serendipity. Researchers at Moss Landing Marine Laboratories, 650 km up the US Pacific coast from his office at in San Diego, mentioned to Brunson’s team that they happened to have a year’s worth of plankton samples from 2015 sitting quietly in their freezers—including ones chock-full of Pseudo-nitzschia from the bloom.
These were exactly the kind of time-indexed samples that the team needed to take the next step in their research, moving from understanding what caused HABs on a genetic level to identifying the warning signs leading up to a HAB. Things could have gone differently, Allen says. Many discoveries never see the light of day: viable samples languish in freezers, or data gather dust as they wait for robust analysis that never comes, he says.
With the samples in hand, however, the researchers now faced a new challenge. From that slurry of biological material and miscellaneous sea gunk they needed to figure out how to extract and analyze the genetic data lying inside.
Unveiling genetics
The samples researchers netted during and leading up to the bloom—taken off a municipal wharf in nearby Monterey—provided a veritable goldmine of eDNA, genetic material that organisms shed into their surroundings. It has become an increasingly convenient and nonintrusive tool for researchers to get a picture of ecosystem dynamics.
For example, a 2024 study swabbed hawk beaks and talons for DNA and identified what species of animals the birds preyed upon. And in 2022, biogeochemists extracted the oldest DNA ever from river sediments and reconstructed an ecosystem that had existed in the area millions of years ago.
In addition to analyzing eDNA, Brunson and Thukral gleaned still more information using transcriptomics, a growing subfield of bioinformatics that catalogs the entirety of an organism’s RNA. By seeking out gene transcripts, such as ribosomal RNA, that differ between species, they could chart the evolution of the 2015 bloom—like how Pseudo-nitzschia australis had become the dominant diatom by April and had maintained its dominance into autumn.
Aware of the ocean conditions in the days leading up to the bloom—low iron and low silicon concentrations—Brunson and Thukral started to put together the puzzle pieces. Thukral’s efforts uncovered dabA’s molecular coconspirator: the gene sit1, which helps transport silicon compounds into Pseudo-nitzschia cells. She found that when silicon was at its scarcest in early summer 2015, expression of sit1 skyrocketed as the algal cells tried to eke more silicon out of the water to build their cell walls and divide.
Thukral figured out that when Pseudo-nitzschia express both genes at the same time—dabA when the algae are starting to synthesize domoic acid and sit1 as they struggle to divide themselves—it could serve as a “robust predictor” that the Pseudo-nitzschia are about to become a toxic powerhouse.
Sorting through and properly analyzing this treasure trove of genetic data—along with data on oceanographic conditions, community composition, and metabolomics—took the team years. “But it becomes pretty beautiful when you’re able to see patterns that are linking them together, and trying to crack the code as to what is taking place in the ocean that we can’t really see with our naked eye,” Thukral says. “All of this data allows us to chip away at that.”
A bit of notice
The team’s metabolomic investigations fell under the umbrella of a US National Oceanic and Atmospheric Administration (NOAA) research program dedicated to the ecology and oceanography of HABs. Their discoveries from plumbing the depths of environmental genetic data are a step toward something coveted by scientists and fisheries alike: the ability to predict blooms as much as a week before they erupt.
“It’s been exciting, because my field has always been prediction,” says SCCOOS’s Anderson, whose work has involved both remote sensing—such as monitoring HAB formation from space—and developing models that might help predict toxin formation. “But we’re always missing a lot of this fundamental knowledge. I’m really confident that now that we can do some of this molecular forecasting, that we’re a little closer towards a truly mechanistic understanding.”
Vera Trainer, the director of the University of Washington’s Olympic Region Harmful Algal Bloom program, who was not involved with Thukral’s study, will be happy for any help she can get. In the Pacific Northwest of the US, the current warning system has its shortcomings because it requires physically counting phytoplankton cells in water samples and measuring their toxin concentration. By the time high concentrations of toxin can be detected, however, a HAB may already be in progress. “If we had a week’s early warning using these genetic approaches, that would be great,” Trainer says.
She adds that toxic blooms also have an outsized impact on members of the Quinault Indian Nation, on the southwestern corner of Washington’s Olympic Peninsula, who have harvested razor clams for thousands of years. “How do you place a value on the loss of shellfish that you’ve been harvesting for centuries with your family?” Trainer asks. Genetic forecasting using eDNA could allow communities to harvest either before a bloom arrives or in unaffected locations.
“It’s an element ingrained into their lives,” Trainer says. “And when they cannot harvest, it’s damaging not just to their economic well-being, but their cultural well-being.”
Next steps
One of the relative weaknesses of the team’s data had nothing to do with their abilities. Their limitation lay in not having enough samples from the beating heart—the initiation sites—of the HABs.
“Where we really want to go next is more directed bloom sampling,” Brunson explains. For samples like those taken by the Moss Landing researchers at a local wharf, “you’re getting a unique environment that might not be precisely like the epicenter of the bloom.” As such, the gene expressions of the HAB that occurred on Moss Landing’s doorstep still need to be confirmed against those of other regions.
Brunson and Thukral’s fellow researchers back at the Monterey Bay Aquarium Research Institute have spent years developing new ocean technology that could provide these genetic samples with robotic precision. Their autonomous underwater vehicles (AUVs) can zoom forth into the ocean depths at a moment’s notice and vacuum up eDNA like an Atlantean Roomba.
Credit: MBARI/Monterey Bay Aquarium
The Monterey Bay Aquarium Research Institute’s autonomous underwater vehicles can prowl water bodies for signs of harmful algal blooms. They take water samples and even do onboard chemical analysis.
The AUV is outfitted with sensors that can continuously hunt for environmental markers so it can pilot itself into the thick of a HAB. This vehicle can then take “sips” of the surrounding water and store what it finds in one of dozens of filters. Researchers then have the choice to bring those samples ashore for hands-on analysis or have the AUV’s onboard systems get a quick look at their molecular components. Ryan says the AUV is “basically a laboratory in a can” that can lyse cells and analyze their contents using a light-based technique called surface plasmon resonance that can detect domoic acid.
“Once you prepare that vehicle with all the reagents inside, you need to wait for the right moment,” Ryan says. “Maybe it’s a mortality event: you see animals dying from domoic acid poisoning. You then remotely send your AUV on its mission to 1) map the phytoplankton distributions, and 2) report back real-time detection information.”
NOAA does, in fact, already have a fleet of ocean gliders monitoring the oceans, “but most of them aren’t out sniffing HABs,” Anderson explains.
SCCOOS has also stationed along the California coastline a fleet of a dozen robotic microscopes, dubbed Imaging FlowCytobots, that can photograph and identify each phytoplankton in 15 mL of water every hour.
Another set of approaches that could one day complement monitoring and data collection are prevention, control, and mitigation. In other words, scientists could use what they know to try to proactively intervene in natural processes to stop HABs from proliferating.
That line of thinking raises pragmatic and philosophical questions: Will advances in molecular forecasting lead to techniques that can circumvent HAB formation, and can the consequences of this sort of geoengineering be known?
Inside the hull of Monterey Bay Aquarium Research Institute’s autonomous underwater vehicles is an onboard system that can collect water the samples for hands-on testing in the lab or do surface plasmon resonance analysis on site.
“Once that horse has left the stable, it’s left the stable,” Anderson admits. In systems the size of the world’s oceans, preventive actions would require intervention on truly massive scales. “They’re much more effective in closed, freshwater systems, and there’s a ton of work being done in that field—with a lot of industry buy-in because they can make all kinds of chemicals that can effectively deal with this. But I do believe that [prevention, control, and mitigation] aspirations in the marine environment are a lot trickier.”
Going forward, however, the transcriptomic techniques that Brunson and Thukral used will also continue to bloom. The sheer amount of biological data circulating through the environment provides more material than could be analyzed by any one laboratory or in any one lifetime.
“That’s one of the amazing things about such a rich data set like this: there’s always so much to explore and learn,” Thukral says.
Jonathan Feakins is a freelance science and history writer based in Chicago. A version of this story first appeared in ACS Central Science: cenm.ag/algalblooms.
Movie franchises come and go, but The Twilight Saga is truly immortal.
The supernatural drama series, an adaptation of Stephenie Meyer’s best-selling young adult novels, follows the against-all-odds romance of high schoolers Bella Swan (Kristen Stewart) and Edward Cullen (Robert Pattinson).
Unlike most teen love affairs, the couple’s relationship is complicated by the reality that Edward is secretly a centenarian vampire with a thirst for blood. Bella’s life is thrown into further disarray when she befriends Jacob Black (Taylor Lautner), a fledgling werewolf who descends from a pack that has an uneasy relationship with the Cullen clan.
‘Twilight’ turns 20: Here’s your refresher on the iconic vampire books
Following the 2008 debut of “Twilight,” the franchise exploded into a pop culture phenomenon, raking in $3.4 billion worldwide across five films. Bella and Edward’s star-crossed romance, which includes an angsty love triangle with Jacob, inspired legions of “Twihards” to declare their allegiance to “Team Edward” or “Team Jacob.”
In honor of the third installment “Eclipse,” released 15 years ago on June 30, 2010, we take a fresh bite and rank the movies from worst to best:
Join our Watch Party! Sign up to receive USA TODAY’s movie, TV recommendations right in your inbox
5. ‘Breaking Dawn – Part 2’ (2012)
How do you say goodbye to a group of vampires who live forever?
The conclusion of The Twilight Saga makes a mighty attempt, focusing on Bella’s long-awaited transformation into a vampire and the raising of Bella and Edward’s half-human, half-vampire daughter Renesmee (Mackenzie Foy). Despite the cuteness of it all, that CGI face of newborn Nessie was … a choice.
The thrill of Bella exploring her vampiric powers is truly a treat; the lamb becomes the lioness thanks to her own super-speed, inexhaustible strength and nifty force field-generation. On the parenting front, Bella and Edward are thrust into a race against time, albeit a sluggishly paced one, as they gather family witnesses to prove to the Volturi that Renesmee is not a threat to vampirekind.
4. ‘Twilight’ (2008)
Arizona transplant Bella attempts to acclimate to life in Forks, Washington, after moving in with her divorced father (Billy Burke), only to become captivated by aloof classmate Edward and his equally enigmatic group of siblings.
Bella and Edward’s meet-cute is fraught with painfully awkward conversations, sullen stares and a near-death by runaway van. The exposition required by their oil-and-water dynamic means the film isn’t as action-heavy as its sequels (with the exception of a rogue trio of murderous vampires, of course).
But the suspenseful mystery packed into Bella’s pursuit of Edward’s true identity, enhanced by cinematographer Elliot Davis’ eerie visuals, makes for a riveting introduction to the franchise. And with an immaculate soundtrack boasting moody alternative-rock, “Twilight” is a haunting you won’t want to exorcise.
3. ‘Breaking Dawn – Part 1’ (2011)
For a paranormal love story, “Breaking Dawn − Part 1” is probably as close as Twihards will ever get to a feel-good flick. The film kicks off in a haze of marital bliss as Bella and Edward prepare for their wedding, after Edward proposes marriage as a condition for turning Bella into a vampire (leave it to an undead bloodsucker to keep tradition alive.)
Unfortunately, the couple’s newlywed fun is cut short when Bella unexpectedly finds herself pregnant on their honeymoon. Shockingly, Bella successfully gives birth in a body-horror extravaganza that is both gut-wrenching and mesmerizing. And if your heart wasn’t pounding already, Edward saves Bella from a post-delivery death in a nail-biting finale.
2. ‘New Moon’ (2009)
Bella hits rock bottom in this somber yet action-packed follow-up to “Twilight.” After Edward abruptly breaks up with her − in a cloaked effort to shield her from the dangers of the vampire world − grief-stricken Bella copes with a rebellious adrenaline junkie phase and her deepening friendship with Jacob.
Jacob, who has secrets of his own as he comes to terms with his werewolf power, is a shaft of earthy sunshine compared to Edward’s often icy veneer. Don’t get me wrong: The intense smolder of a bloodthirsty vampire would make my heart flutter, too. But Jake is cut from a softer cloth, and his warmth is an emotional salve for our distraught heroine Bella.
Bella’s brewing situationship with Jacob is thwarted by a whirlwind reunion with Edward in Italy. The happy ending is undoubtedly a win for the hopeless romantics (and not to mention Team Edward stans), but the pragmatist in me can’t help but root for the underwolf and his grounded charm.
1. ‘Eclipse’ (2010)
It’s not just the anniversary talking, folks. “Eclipse” is the soapy, hormonally charged climax of the franchise that solidifies the trifecta of Bella’s intense bonds with Edward and Jacob.
Bella’s reconciliation with Edward reaffirms her desire to become a vampire, while Jacob, futilely, maintains his dogged pursuit of her affections. The push and pull lends itself to some juicy dramatic tension, with Jacob even taking a punch to the face after a spur-of-the-moment kiss goes awry.
The impending invasion of Victoria (Bryce Dallas Howard) and her army of newborn vampires inspires an unlikely alliance between the Cullen coven and Jacob’s Quileute pack, setting the stage for some kickass action sequences. In the afterglow of their victory, Bella tells a battle-injured Jacob that she’s chosen Edward as her partner in a finale that’s as heartbreaking as it is infuriating.
Somerset 17-year-old Thomas Rew hit the fastest one-day century for England Under-19s as they levelled their 50-over series against India with a tense one-wicket win in Northampton.
England captain Rew made a sublime 131 from 89 balls, an innings packed full of effortless strokeplay, to break the back of a chase of 291 with England winning with three balls to spare.
Rew’s dismissal in the 40th over was the first of five lost for 49, leaving final pair Seb Morgan and Alex French to get 12 from 11 balls.
But while Morgan showed superb nerve to end 20 not out – he hit a four to seal the win halfway through the final over – the match will be best remembered for the innings of diminutive right-hander Rew, the younger brother of recent England call-up James.
Having come in at 47-3, Rew reached three figures in 73 balls – six deliveries quicker than Ben Foakes, who held the record after his century against New Zealand in 2012.
He put on 123 in 128 balls with Rocky Flintoff, the son of England legend Andrew, who was England’s next highest scorer with 39 off 68.
Rew targeted the leg side against India’s spinners with powerful pulls and slog sweeps while also playing an inventive reverse sweep for four, a glorious drive high over long-on off leg-spinner Mohammed Enaan for six and taking seamer RS Ambrish for 19 runs in one over with off-side drives.
And while his highly-rated brother has scored 10 first-class centuries by the age of 21, he did not score a century at Under-19 level, meaning the younger sibling has pipped him to that mark.
“There is a lot of competition in our family,” Rew said. “He messaged me just now saying ‘well done’ which is nice of him.
“It is up there [with the best innings he has played]. Once I got going I targeted the short boundary and tried to put the pressure back on the bowlers.
“The way Rocky spoke to me and we batted together, really helped us get on the front foot.”
Rew joined Somerset’s academy in 2023, a year after his brother, now 21, made his first-class debut.
James, who has said Thomas is “further ahead” than him at the same age, was named the Professional Cricket Association’s men’s young player of the year in 2023, having become Somerset’s youngest double centurion earlier that year.
He was called into England’s squad for the one-off Test against Zimbabwe earlier this year but did not play.
The five-match series continues at Northampton on Wednesday.
Vaibhav Suryavanshi, the 14-year-old who hit a century in the Indian Premier League earlier this year, also made 45 in India’s 290 all out. Surrey seamer French took 4-71 for England.